Table 4.
Projected additional male cases of HIV and additional direct medical costsa.
| African American n = 6399 |
White n = 5776 |
Other n = 2680 |
Total n = 14,855 |
|
|---|---|---|---|---|
| Baseline prevention fraction (60%)b | ||||
| Additional HIV cases | 48 | 2 | 5 | 55 |
| Additional cost discounted to time of infectionc | $18,252,700 | $739,100 | $1,932,600 | $20,924,400 |
| Additional cost discounted to birthd | $7,150,000 | $294,600 | $804,200 | $8,248,800 |
|
| ||||
| Highest prevention fraction (80%)b | ||||
| Additional HIV cases | 85 | 4 | 8 | 97 |
| Additional cost discounted to time of infectionc | $31,942,200 | $1,612,600 | $2,989,000 | $36,543,800 |
| Additional cost discounted to birthd | $12,512,400 | $642,700 | $1,206,300 | $14,361,400 |
|
| ||||
| Lowest prevention fraction (39%)b | ||||
| Additional HIV cases | 24 | 1 | 3 | 28 |
| Additional cost discounted to time of infectionc | $9,126,300 | $336,000 | $966,300 | $10,428,600 |
| Additional cost discounted to birthd | $3,575,000 | $133,900 | $402,100 | $4,111,000 |
aPer South Carolina Medicaid birth year cohort.
bPrevention fraction (1-relative risk) of male circumcision for reducing HIV transmission through heterosexual contact.
cUsing Schackman et al's discounted lifetime HIV treatment cost of $303,100 (in $US2004) inflated to $US2010 for a lifetime treatment cost of $377,360.
dTo allow for direct comparison to circumcision savings in the cohort birth year.